Follow the 扶桑薬品工業株式会社 stock price and the full management transaction log of the company, a publicly traded company based in Japan. Shares trade on the JP market, under the oversight of EDINET (Japan FSA). Market capitalisation: €19.8bn. The latest transaction was disclosed on 5 June 2026 (Holding update). Among the most active insiders: SMBC Nikko Securities Inc.. Every trade is free.
13
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 18,036 of 29,053 companies
44.5
score / 100
Value
53
Quality
36
FCF yld-40%
Earn yld10%
EV/EBITDA8.9x
ROE6.4%
Gross mgn26%
Net mgn3.2%
Debt/EBITDA5.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.